Confo Therapeutics

About:

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

Website: http://confotherapeutics.com

Top Investors: Perceptive Advisors, Wellington Partners, Capricorn Partners, PMV, BioGeneration Ventures

Description:

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO body-stabilized active state conformations of these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.

Total Funding Amount:

109M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Founded Date:

2015-01-01

Contact Email:

info(AT)confotherapeutics.com

Founders:

Jan Steyaert, Toon Laeremans

Number of Employees:

51-100

Last Funding Date:

2024-07-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai